Matching Items (8)
Filtering by
- All Subjects: medicine
- Creators: School of Historical, Philosophical and Religious Studies
Description
Human subject research is a sensitive ethical topic in today's society, and with good cause. The history of human subject research is full of tragedy and wrongdoing, which is what has led to the firm restrictions we presently have. At the same time, we also acknowledge the value behind human subject research and the information science can obtain from such endeavors. This project analyzes this conundrum through a narrative describing a group of scientists who choose to ignore some of the laws and regulations concerning human subject research in order to pursue neurological based research for a "greater good." In the novella, the scientists end up harming several people while performing their illegal research, but are able to obtain successful results. However, the group is eventually caught, and end up having to face the consequences of their actions. The situations and interactions the story presents are meant to juxtapose both sides of the human subject research ethical argument in a unique way in order to allow the reader to critically think through the argument themselves and form their own opinions on the matter.
ContributorsPirotte, Benjamin Daniel (Author) / Finn, Edward (Thesis director) / Cook, Paul (Committee member) / McGregor, Joan (Committee member) / Barrett, The Honors College (Contributor) / School of Life Sciences (Contributor) / School of Historical, Philosophical and Religious Studies (Contributor)
Created2015-05
Description
This project looks at ways in which the individual comes into contact with history. By looking at the Katyń Massacre, we can see how violence and history can be viewed from aesthetic perspectives. This allows us to take part in the conversations concerned with genocide in other ways than from ethical and sympathetic perspectives. By examining the Katyń through an aesthetic lens, the individual can approach violence in new and unique ways. This research highlights for us a new way of approaching history and violence while simultaneously offering a way for the individual to have a new voice in history. The poetry that follows the research offers a way for us to aestheticize violence and use language to approach it in a way that is simultaneously cruel and beautiful.
ContributorsTucker, Robert Charles Austin (Author) / Sarah, Ball (Thesis director) / Castle, Gregory (Committee member) / Barrett, The Honors College (Contributor) / School of Historical, Philosophical and Religious Studies (Contributor) / Department of English (Contributor)
Created2015-05
Description
Modern medicine is a wonderfully complex field of study, with several advances in both its theoretical and practical aspects being made everyday. In light of the pride modern physicians and scientists take in their vast knowledge, it is important to remember how far we have come throughout history. Many civilizations and cultures around the world have made essential contributions to medicine, both great and small, but no one can deny the impact both ancient Chinese and Islamic medical and alchemical practices have had on modern medicine. Qi was the central principle behind Chinese correlative thought, and it was believed to be the one thing that drove human life, as it occurred everywhere. Written texts took an increasingly more prominent role in the transmission of knowledge, and in no time at all, the educated yi ("physician") emerged. Other noteworthy contributions include an early conceptualization of the circulatory system, the development of pharmacies, the establishment of proper medical school systems, and the emergence of a set of standard hygienic practices that would allow people to take responsibility for their own health. The scholars of the Islamic Golden Age, for the most part, seemed to decry the mixing of the occult with science, and therefore sought to draw a clear distinction between alchemy (by limiting its application to the transmutation of metals) and what they deemed "real" science. Notable contributions of Arab-Islamic scientists include the pioneering of a hospital prototype, along with the development of the science of chemistry and the introduction of the experimental laboratory as the birthplace of new scientific knowledge. The important question that has yet to be answered is how extensive the connection was between the Chinese and Arab worlds. Trade was thriving during the medieval period, and so it is not wrong to assume that the exchange of goods would go hand-in-hand with the exchange of knowledge. We may never fully know exactly what happened, but further research on this topic may eventually bring an answer to light.
ContributorsRaban, Miranda Meriam (Author) / Bokenkamp, Stephen (Thesis director) / Ling, Xiaoqiao (Committee member) / Ali, Souad T. (Committee member) / School of Historical, Philosophical and Religious Studies (Contributor) / Barrett, The Honors College (Contributor)
Created2018-05
Description
Glioblastoma multiforme (GBMs) is the most prevalent brain tumor type and causes approximately 40% of all non-metastic primary tumors in adult patients [1]. GBMs are malignant, grade-4 brain tumors, the most aggressive classication as established by the World Health Organization and are marked by their low survival rate; the median survival time is only twelve months from initial diagnosis: Patients who live more than three years are considered long-term survivors [2]. GBMs are highly invasive and their diffusive growth pattern makes it impossible to remove the tumors by surgery alone [3]. The purpose of this paper is to use individual patient data to parameterize a model of GBMs that allows for data on tumor growth and development to be captured on a clinically relevant time scale. Such an endeavor is the rst step to a clinically applicable predictions of GBMs. Previous research has yielded models that adequately represent the development of GBMs, but they have not attempted to follow specic patient cases through the entire tumor process. Using the model utilized by Kostelich et al. [4], I will attempt to redress this deciency. In doing so, I will improve upon a family of models that can be used to approximate the time of development and/or structure evolution in GBMs. The eventual goal is to incorporate Magnetic Resonance Imaging (MRI) data into a parameterized model of GBMs in such a way that it can be used clinically to predict tumor growth and behavior. Furthermore, I hope to come to a denitive conclusion as to the accuracy of the Koteslich et al. model throughout the development of GBMs tumors.
ContributorsManning, Miles (Author) / Kostelich, Eric (Thesis director) / Kuang, Yang (Committee member) / Preul, Mark (Committee member) / Barrett, The Honors College (Contributor) / College of Liberal Arts and Sciences (Contributor)
Created2012-12
Description
Cardiovascular disease is one of the most deadly outcomes of end stage renal disease. Bioelectrical impedance is a intriguing, yet unproven method of measuring fluid buildup in the heart, and is marketed as a early diagnostic tool for onset of cardiovascular disease. In this study, selenium supplements were given to a cohort of dialysis patients in the Phoenix metro area and their fluid tolerance was measured with thoracic biolectrical impedance. BNP was used as a correlate to see if bioelectrical impedance was correlated with heart disease. The study found no correlation between BNP and bioelectrical impedance and thus was not an accurate diagnostic tool in a medical setting.
ContributorsBrown, Patrick Michael (Author) / Johnston, Carol (Thesis director) / Orchinik, Miles (Committee member) / Tingey, Michael (Committee member) / Barrett, The Honors College (Contributor) / School of Life Sciences (Contributor) / School of Historical, Philosophical and Religious Studies (Contributor)
Created2013-05
Description
De Plantis Aegypti is a medical botany text from 1592, written by Prospero Alpini in Latin. In this text, Alpini details a variety of plants native and grown in Egypt, how they are grown, how they are processed, what they look like, and what if any edible and medical uses are documented. This project focused on transcribing and editing the Latin text, translating the Latin text into English, and comparing the medical claims to the modern scientific literature. This is the first translation of this text into English or any other language. Alpini also wrote two other books, which also have never been translated. The intended goal was to demonstrate that renaissance scholars understood medicine well, if not the mechanisms through which those medicines worked. After analyzing the modern scientific literature on the plants mentioned within the text, it was found that every medical use referenced in the text was either directly supported, indirectly supported, or there was no data from the literature. In other words, none of the medical uses were found to be disproved. On the other hand, quite a few of the plants actually had similar efficacies as modern pharmaceuticals. In addition to the notes on the modern science, there are also quite a few notes based on the grammar and the orthography of the text. This project is but a sampling of the plants mentioned De Plantis Aegypti, there are dozens more, which I plan on translating and doing a similar analysis on at a later date.
ContributorsPlamondon, Ian Lee (Author) / Poudrier, Almira (Thesis director) / Bjork, Robert (Committee member) / Egmond, Warren (Committee member) / School of Historical, Philosophical and Religious Studies (Contributor) / School of Molecular Sciences (Contributor) / School of International Letters and Cultures (Contributor) / School of Human Evolution and Social Change (Contributor) / Barrett, The Honors College (Contributor)
Created2016-05
Description
Adaptive therapy utilizes competitive interactions between resistant and sensitive cells by keeping some sensitive cells to control tumor burden with the aim of increasing overall survival and time to progression. The use of adaptive therapy to treat breast cancer, ovarian cancer, and pancreatic cancer in preclinical models has shown significant results in controlling tumor growth. The purpose of this thesis is to draft a protocol to study adaptive therapy in a preclinical model of breast cancer on MCF7, estrogen receptor-positive, cells that have evolved resistance to fulvestrant and palbociclib (MCF7 R). In this study, we used two protocols: drug dose adjustment and intermittent therapy. The MCF7 R cell lines were injected into the mammary fat pads of 11-month-old NOD/SCID gamma (NSG) mice (18 mice) which were then treated with gemcitabine.<br/>The results of this experiment did not provide complete information because of the short-term treatments. In addition, we saw an increase in the tumor size of a few of the treated mice, which could be due to the metabolism of the drug at that age, or because of the difference in injection times. Therefore, these adaptive therapy protocols on hormone-refractory breast cancer cell lines will be repeated on young, 6-week old mice by injecting the cell lines at the same time for all mice, which helps the results to be more consistent and accurate.
ContributorsConti, Aviona (Author) / Maley, Carlo (Thesis director) / Blattman, Joseph (Committee member) / Seyedi, Sareh (Committee member) / School of Life Sciences (Contributor, Contributor) / Barrett, The Honors College (Contributor)
Created2021-05
Description
Efforts to treat prostate cancer have seen an uptick, as the world’s most commoncancer in men continues to have increasing global incidence. Clinically, metastatic
prostate cancer is most commonly treated with hormonal therapy. The idea behind
hormonal therapy is to reduce androgen production, which prostate cancer cells
require for growth. Recently, the exploration of the synergistic effects of the drugs
used in hormonal therapy has begun. The aim was to build off of these recent
advancements and further refine the synergistic drug model. The advancements I
implement come by addressing biological shortcomings and improving the model’s
internal mechanistic structure. The drug families being modeled, anti-androgens,
and gonadotropin-releasing hormone analogs, interact with androgen production in a
way that is not completely understood in the scientific community. Thus the models
representing the drugs show progress through their ability to capture their effect
on serum androgen. Prostate-specific antigen is the primary biomarker for prostate
cancer and is generally how population models on the subject are validated. Fitting
the model to clinical data and comparing it to other clinical models through the
ability to fit and forecast prostate-specific antigen and serum androgen is how this
improved model achieves validation. The improved model results further suggest that
the drugs’ dynamics should be considered in adaptive therapy for prostate cancer.
prostate cancer is most commonly treated with hormonal therapy. The idea behind
hormonal therapy is to reduce androgen production, which prostate cancer cells
require for growth. Recently, the exploration of the synergistic effects of the drugs
used in hormonal therapy has begun. The aim was to build off of these recent
advancements and further refine the synergistic drug model. The advancements I
implement come by addressing biological shortcomings and improving the model’s
internal mechanistic structure. The drug families being modeled, anti-androgens,
and gonadotropin-releasing hormone analogs, interact with androgen production in a
way that is not completely understood in the scientific community. Thus the models
representing the drugs show progress through their ability to capture their effect
on serum androgen. Prostate-specific antigen is the primary biomarker for prostate
cancer and is generally how population models on the subject are validated. Fitting
the model to clinical data and comparing it to other clinical models through the
ability to fit and forecast prostate-specific antigen and serum androgen is how this
improved model achieves validation. The improved model results further suggest that
the drugs’ dynamics should be considered in adaptive therapy for prostate cancer.
ContributorsReckell, Trevor (Author) / Kostelich, Eric (Thesis advisor) / Kuang, Yang (Committee member) / Mahalov, Alex (Committee member) / Arizona State University (Publisher)
Created2020